Search research articles
Contact Us
Filters
Showing results (231-240 of 466) with videos related to
Page
of 47
Sort By:
Aging Cell
|
February 8, 2026
Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent Fibroblasts
Albert Kallon Koroma, Karmveer Singh, Yongfang Wang, et al.
Leukemia
|
May 6, 2022
The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia
Lisa Rusyn, Sebastian Reinartz, Anastasia Nikiforov, et al.
British Journal of Haematology
|
November 22, 2018
Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia
Othman Al-Sawaf, Jasmin Bahlo, Sandra Robrecht, et al.
Leukemia
|
August 21, 2021
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients
Selcen Öztürk, Yashna Paul, Saira Afzal, et al.
Blood
|
April 20, 2004
Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions
Holger Kohlhammer, Carsten Schwaenen, Swen Wessendorf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2006
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation
Thorsten Zenz, Richard F Schlenk, Gerhard Glatting, et al.
Haematologica
|
October 30, 2020
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440)
Stephan Stilgenbauer, Franck Morschhauser, Clemens-Martin Wendtner, et al.
Haematologica
|
January 13, 2018
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin
Claudia Dürr, Bola S Hanna, Angela Schulz, et al.
Leukemia & Lymphoma
|
September 19, 2022
Pooled analysis of first-line treatment with targeted agents in patients with chronic lymphocytic leukemia aged 80 years and older
Florian Simon, Adam Giza, Sandra Robrecht, et al.
Haematologica
|
October 8, 2008
Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes
Katrina Vanura, Trang Le, Harald Esterbauer, et al.
Page
of 47
Search research articles
Search
Showing results (231-240 of 466) with videos related to
Sort By:
Page
of 47
Aging Cell
|
February 8, 2026
Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent Fibroblasts
Albert Kallon Koroma, Karmveer Singh, Yongfang Wang, et al.
Leukemia
|
May 6, 2022
The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia
Lisa Rusyn, Sebastian Reinartz, Anastasia Nikiforov, et al.
British Journal of Haematology
|
November 22, 2018
Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia
Othman Al-Sawaf, Jasmin Bahlo, Sandra Robrecht, et al.
Leukemia
|
August 21, 2021
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients
Selcen Öztürk, Yashna Paul, Saira Afzal, et al.
Blood
|
April 20, 2004
Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions
Holger Kohlhammer, Carsten Schwaenen, Swen Wessendorf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2006
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation
Thorsten Zenz, Richard F Schlenk, Gerhard Glatting, et al.
Haematologica
|
October 30, 2020
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440)
Stephan Stilgenbauer, Franck Morschhauser, Clemens-Martin Wendtner, et al.
Haematologica
|
January 13, 2018
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin
Claudia Dürr, Bola S Hanna, Angela Schulz, et al.
Leukemia & Lymphoma
|
September 19, 2022
Pooled analysis of first-line treatment with targeted agents in patients with chronic lymphocytic leukemia aged 80 years and older
Florian Simon, Adam Giza, Sandra Robrecht, et al.
Haematologica
|
October 8, 2008
Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes
Katrina Vanura, Trang Le, Harald Esterbauer, et al.
Page
of 47